Trending
April 23, 2024 Incyte to Acquire Escient PharmaceuticalsMarch 19, 2024 Rapport Therapeutics Appoints John Maraganore to Board of DirectorsMarch 7, 2024 Johnson & Johnson Completes Ambrx AcquisitionMarch 5, 2024 Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic PartnersFebruary 28, 2024 Rapport Therapeutics Appoints Kathy Wilkinson as Chief People Officer